OCRA Team
Meet Our Team
OCRA is fortunate to have a Board composed of distinguished leaders, a team of talented, caring Staff members, and a renowned Scientific Advisory Committee, who between them have decades of experience fighting ovarian and related gynecologic cancers. Passionate, knowledgeable, and innovative, they are dedicated to improving the lives of those touched by the disease through advancing research, creating imaginative, empathic support programs, encouraging industry collaboration, and fighting legislative battles on Capitol Hill.
Learn About Our Team Members
Never doubt that a small group of thoughtful committed citizens can change the world: indeed, it’s the only thing that ever has.
Related Topics
Mission & Impact
OCRA is dedicated to improving treatments by advancing innovative research, supporting with expertise and empathy those affected by gynecologic cancers to ensure the best possible care and outcomes, raising awareness, and advocating for legislation that tangibly improves patients’ lives.
AWS Highlights OCRA’s Research Exchange in $100 Million Health Impact Initiative
Recognition underscores the potential of OCRA’s innovative approach to accelerating gynecologic cancer research through AI, data sharing, and collaboration. Amazon Web Services (AWS) has launched its Health Impact Initiative, a $100 million, five-year commitment to putting AI, advanced computing, and cloud infrastructure in the hands of organizations working to address some of the world’s most … Continued
OCRA Names Dmitriy Zamarin, MD, PhD, as 2026 Liz Tilberis Research Prize Winner
Dmitriy Zamarin, MD, PhD, has been awarded the 2026 Liz Tilberis Research Prize for Outstanding Early Career Investigators by Ovarian Cancer Research Alliance (OCRA). A physician-scientist whose research has explored new approaches to harnessing the immune system against ovarian cancer, Dr. Zamarin is Professor of Oncology, Section Head of Gynecologic Medical Oncology, and Co-Director of … Continued